Dr. Brian Eugene Kadera, MD

Dr. Kadera practices at Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles.

Dr. Kadera's NPI, 1083849327, was assigned on May 15, 2009. Dr. Kadera graduated from Duke University School Of Medicine in 2009. Dr. Kadera holds California license A113956.

Dr. Kadera's primary practice is Olive View-UCLA Medical Center, at 14445 Olive View Drive, Sylmar, CA 91342 in Los Angeles County. The practice phone is (818) 364-1555.

Dr. Kadera's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dr. Kadera is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Surgical Oncology Associates. Dmand AI also links Dr. Kadera to 1 more hospital, 1 community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadera practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Kadera's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Kadera is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Kadera's licenses on file in 2 states: California and New York.

Dmand AI lists abdominal adhesion surgery among the conditions Dr. Kadera treats.

CMS data shows 38 Medicare services from Dr. Kadera across 2 procedure codes in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $6,513 for them. Every service was in an office.

CMS counts 39 Medicare patients who saw Dr. Kadera in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadera's median patient age at 62, with 45% women.

In 2024, Dr. Kadera wrote 22 Medicare Part D claims for 11 patients. 86% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kadera for performance year 2024, reported as part of a group. Dr. Kadera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadera as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Kadera, published from 2009 to 2020. The most frequent topics are Diabetes Mellitus, Type 2 and Weight Loss. Dr. Kadera has published most often in Surg Obes Relat Dis. Dr. Kadera's most frequent co-authors are Brian M. Fung, MD and James Hagop Tabibian, MD.

CMS Open Payments shows 5 general payments to Dr. Kadera from 2 drug and device companies from 2018 to 2021. Travel and lodging make up the largest share, 96% of the total. Intuitive Surgical, Inc. paid the most, $600.

Dmand AI lists 3 awards for Dr. Kadera, most recently Gerald S. Levey Research Scholarship in 2013.

Dr. Kadera graduated from Duke University School Of Medicine in 2009. Dr. Kadera is a member of AACR, ACS, ASCO and SSO.

Dr. Kadera is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.